Bladder Cancer Clinical Trials

There are 25 registered clinical trials for Bladder Cancer in the TrialLens index.

Trials (25)

Immunological Variables Associated to ICI Toxicity in Cancer Patients Phase 2 · Jules Bordet Institute
Feasibility of HISA During TURBT for NMIBC N/A · CAMC Health System
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study N/A · Mansoura University
A Study of Intravesical Qapzola (Apaziquone) as a Surgical Adjuvant in Participants Undergoing Transurethral Resection of Bladder Tumor (TURBT) Phase 3 · Spectrum Pharmaceuticals, Inc
Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents Phase 1 · H. Lee Moffitt Cancer Center and Research Institute
Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer Phase 2 · Hospital del Mar
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer Phase 3 · UroGen Pharma Ltd.
Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage N/A · Mansoura University
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors Phase 2 · Telix Pharmaceuticals (Innovations) Pty Ltd
Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy N/A · Dana-Farber Cancer Institute
PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer Phase 2 · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer Phase 1/2 · Halozyme Therapeutics
Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) Phase 2/3 · Endo USA Inc., a Keenova Therapeutics Company
Diagnostic Performance of the Vesical Imaging-Reporting and Data System (VI-RADS) in Detecting Muscle-invasive Bladder Tumour (MIBC) in Clinical Practice: Comparison With Transurethral Resection of Bladder Cancer (TURB) and Evaluation of Diagnostic Accuracy According to Tumour Location N/A · Istituto Nazionale di Ricovero e Cura per Anziani
Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC) Phase 3 · UroGen Pharma Ltd.
Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer N/A · University of Kansas Medical Center
A Study of Surgical Techniques During Cystectomy Phase 3 · Memorial Sloan Kettering Cancer Center
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer Phase 1 · Baylor College of Medicine
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy N/A · University of Miami
Safety Analysis and Oncological Outcomes in HoLERT vs TURBT N/A · Instituto do Cancer do Estado de São Paulo
Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy Phase 1 · M.D. Anderson Cancer Center
Prospective Collection of Samples for Urothelial Cancer of Bladder N/A · Universitaire Ziekenhuizen KU Leuven
The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy Phase 4 · Taha Uçar
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers Phase 1 · Arcus Biosciences, Inc.
Urine DNA Methylation Detection for Hematuria Evaluation N/A · Changhai Hospital

Related landscapes

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.